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Previously, we showed that vitamin D receptor gene
knockout leads to hyperreninemia independent of calcium
metabolism; however, the contribution of parathyroid
hormone to renin upregulation remained unclear. Here we
separated the role of vitamin D and parathyroid hormone in
the regulation of renin expression in vivo by generating
transgenic mice that overexpressed the human vitamin D
receptor in renin-producing cells using the 4.1 kb Ren-1c
gene promoter. Targeting of human vitamin D receptor to
the juxtaglomerular cells of the mice was confirmed by
immunohistochemistry. Renal renin mRNA levels and plasma
renin activity were decreased in these transgenic mice by
about 50% and 30%, respectively, with no significant change
in blood pressure, calcium, or parathyroid hormone levels.
Moreover using vitamin D receptor knockout mice, we found
that expression of the human receptor in their
juxtaglomerular cells reduced renin expression in these mice
without affecting calcium or parathyroid hormone status. Our
study shows that suppression of renin expression by 1,25-
dihydroxyvitamin D in vivo is independent of parathyroid
hormone and calcium.
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The renin–angiotensin system is important in the regulation
of blood pressure and intravascular volume and electrolyte
homeostasis. Renin is the rate-limiting enzyme that converts
angiotensinogen to angiotensin (Ang) I in the renin–Ang
cascade. The circulating renin is mainly generated in the
juxtaglomerular (JG) cells in the kidney, and the production
and release of renin from the JG cells are tightly regulated by
various physiological stimuli, including changes in renal
perfusion pressure, tubular sodium chloride concentrations,
and sympathetic nerve activity.1 At the molecular level, renin
gene expression is regulated by a network of transcription
factors targeting the renin gene promoter.2
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3), the active
metabolite of vitamin D, is a multifunctional hormone that
acts by activating the vitamin D receptor (VDR).3 Our
previous studies have demonstrated that 1,25(OH)2D3
suppresses the renin–Ang system by negatively regulating
renin gene expression,4 and genetically mutant mice lacking
VDR develop hyperreninemia, leading to renal and cardio-
vascular abnormalities.5,6 As VDR knockout (KO) mice also
develop hypocalcemia and secondary hyperparathyroidism,7
it is important to clarify the relationship between these
phenotypes. It is clear from our previous studies that renin
upregulation is not due to the hypocalcemia associated with
VDR inactivation, because normalization of serum calcium
levels by dietary means failed to normalize renin expression
in VDRKO mice;5 however, it remains to be determined
whether the high serum parathyroid hormone (PTH)
concentration contributes to the increase in renin biosynth-
esis. In VDRKO mice, the serum PTH level is very high due
to the secondary hyperparathyroidism, and because of the
loss of VDR-mediated suppression by 1,25(OH)2D3 the PTH
level cannot be completely normalized even when the serum-
ionized calcium level has been normalized by dietary means.5
Therefore, the contribution of PTH to hyperreninemia
cannot be completely excluded in VDRKO mice.
The data reported in the literature are inconclusive and
somewhat conflicting regarding the role of PTH in the
regulation of renin and blood pressure. For example, in one
study PTH was thought to be vasodilative in hypertensive
patients,8 whereas in another PTH infusion was shown to
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cause hypertension in normal subjects.9 PTH was reported to
directly stimulate renin production,10 or increase renin
production by modulation of tubular transport of so-
dium11,12 or calcium.13,14 These inconsistent and mostly
observational data call for a further clarification of PTH effect
on renin regulation.
To address the effect of PTH on renin upregulation and
confirm the repressive role of VDR in renin regulation in
vivo, in the present study we generated transgenic (Tg) mice
that overexpress hVDR in the renin-producing cells. We
demonstrated that the transgene regulates renin biosynthesis
in mice independently of calcium and PTH.
RESULTS
We used the 4.1 kb mouse Ren-1C gene promoter to drive
hVDR expression in Tg mice because this 4.1 kb 50-flanking
region has been shown to contain all the components
required for tissue- and cell-specific expression of renin
gene,15 and this promoter has been successfully used to target
transforming growth factor-b1 and green fluorescent protein
expression in renin-producing cells in Tg studies.16,17 Thus,
this promoter was ideal for our experimental purpose.
Microinjection of the 6.3 kb R1C-hVDR construct
(Figure 1a) resulted in 34 pups born, of which 7 founders
were carrying the hVDR transgene, as identified by PCR and
verified by Southern blotting (Figure 1b).
The expression of the hVDR transgene in Tg mouse lines
was measured by northern (Figure 1c) and western blot
analyses (Figure 1d) in the kidney of Tg line 35 (high copy
number) and line 25 (low copy number). To see the maximal
effect, we focused on Tg-35 in the following investigations.
Immunostaining of kidney sections of Tg-35 mice with anti-
VDR antibody localized hVDR transgene expression in the JG
apparatus (Figure 1e). As reported previously,16 a very low
level of hVDR mRNA was detectable by reverse transcripta-
se–PCR in the submandibular gland of Tg-35 mice (data not
shown).
We first determined the effect of the hVDR transgene on
serum-ionized calcium and PTH levels. As shown in Figure 2,
the values of serum-ionized calcium (Figure 2a) and intact
PTH (iPTH) (Figure 2b) in Tg mice were within the normal
range compared to wild-type (Wt) mice (Caþ þ (mM): Tg
(n¼ 4), 1.36±0.06 vs Wt (n¼ 7), 1.34±0.04; iPTH (pg/ml),
Tg, 18.7±3.2 versus Wt, 17.9±7.2). These data indicate that
the hVDR transgene had no effects on the PTH and calcium
status in Tg mice.
We then determined the effect of the hVDR transgene on
renin biosynthesis and blood pressure. Northern blot analysis
showed that renin mRNA expression in the kidney was clearly
reduced in Tg mice by more than 50% compared to the Wt
counterparts (Figure 2c and d). The plasma renin activity
(PRA) was reduced by about 30% in Tg mice compared to
Wt mice (Figure 2e). These data are consistent with the
notion that VDR downregulates renin expression. However,
the mean blood pressure was not different between Tg and
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Figure 1 | Generation of hVDR transgenic mice. (a) Schematic
map of the R1C4.1-hVDR DNA construct used for microinjection in
Tg mouse production. P, PmeI; X, XbaI; E, EcoRI; H, HindIII; K, KpnI.
(b) Identification hVDR-Tg lines by Southern blot analysis.
Genomic DNA (10 mg per lane) isolated from tail samples of Tg
lines were digested with BglII, separated with 0.8% agarose gel,
and probed with 32P-labeled hVDR cDNA. Wt, wild-type control.
(c) Northern blot showing expression of the hVDR transgene in Tg
lines 25 and 35. (d) Western blot analysis of kidney lysates from Wt
and Tg lines 25 and 35 with anti-VDR antibody. (e)
Immunostaining of kidney sections of Wt and Tg-35 mice with
anti-VDR antibody. Arrows indicate a strong staining in the JG
region of the glomerulus.
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Figure 2 | Effect of the hVDR transgene on serum calcium and
PTH status and renin biosynthesis. (a) Serum-ionized calcium
levels; and (b) serum-intact PTH levels in Wt and Tg mice. (c)
Northern blot showing renin mRNA levels in the kidney of Wt and
Tg mice. (d) Quantification of renin mRNA in Wt and Tg mice
based on the northern blot data. (e) Plasma renin activity (PRA) in
Wt and Tg mice. (f) Mean blood pressure (BP) in Wt and Tg mice.
Wt, wild-type mice, Tg, transgenic mice; *Po0.05 vs Wt, nX4.
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Wt mice (Figure 2f), indicating that the effect of hVDR
transgene was not enough to change the blood pressure.
The next question is whether the hVDR transgene is able
to normalize renin expression when it is reconstituted into
the JG cells in VDRKO mice. The JG cells are highly
specialized smooth muscle cells located in the afferent
arteriole of the nephron. The main function of these cells is
to produce and secret renin, and they are not involved in the
regulation of calcium metabolism or PTH secretion. So
reconstitution of VDR in these cells is not expected to change
calcium and PTH status. To this end, we generated VDRKO
mice that expressed the hVDR transgene in the JG cells (Tg-
KO). Like VDRKO mice, Tg-KO mice also developed
hypocalcemia and secondary hyperparathyroidism, and
serum-ionized calcium and iPTH levels were not different
between VDRKO and Tg-KO mice (Caþ þ (mM): Tg-KO,
0.89±0.03; VDRKO, 0.91±0.02 vs Wt, 1.36±0.05, and
iPTH (ng/ml): Tg-KO, 1504±236; VDRKO, 1693±174 vs
Wt, 39±5) (Figure 3a and b). Therefore, we confirmed that
the transgene had no effects on the calcium and PTH status
in the VDRKO background. As shown previously,5 renin
expression was upregulated in VDRKO mice compared to Wt
mice. Interestingly, renin mRNA levels in Tg-KO mice were
markedly lower than those seen in VDRKO mice (Figure 3c
and d), indicating that the hVDR transgene was able to rescue
the renin upregulation seen in VDRKO mice. This confirms
that VDR-mediated action of 1,25(OH)2D3 suppresses renin
expression in a calcium- and PTH-independent manner.
DISCUSSION
Our previous studies have shown that VDR inactivation leads
to hyperreninemia in VDRKO mice.5 As VDRKO mice
develop hypocalcemia and secondary hyperparathyroidism,
the elevation of renin production may be caused by VDR
inactivation per se, low serum calcium, high PTH, or a
combination of these factors. We have demonstrated that
renin upregulation is not due to hypocalcemia5 and
1,25(OH)2D3 directly suppresses renin gene transcription in
a VDR-dependent manner in JG cells.4 Other recent studies
have further demonstrated that 1,25(OH)2D3 and activated
vitamin D analogs can suppress renin expression in the
heart18 and mesangial cells.19 Zhou et al.20 have confirmed
that 1,25(OH)2D3 downregulates renin expression in a
calcium-independent manner in 25-hydroxyvitamin D 1a-
hydroxylase knockout mice. However, the in vivo effect of
PTH on renin expression remains unclear. Although no effect
of PTH on renin expression was detected in As4.1 cell
culture,5 it is possible that, because the cyclic AMP–protein
kinase A signaling pathway is constitutively active in these
cells,21 PTH is not able to transduce the signal in these cells.
Therefore, the in vitro effect of PTH on renin expression is
not clear either. Given that PTH is a major endocrine
hormone, it is important to clarify its role in the renin
regulation. One argument is to assess the PTH effect by
treating animals with PTH, but the problem is that PTH will
alter calcium and vitamin D status in the animals, which
complicates the data interpretation.
In the present study we generated Tg mice that over-
express hVDR only in the renin-producing cells, and, as
expected, the hVDR transgene did not alter the status of
calcium and PTH in both wild-type and VDR-null back-
grounds. Like Wt mice, Tg mice had normal calcium and
PTH status, thus allowing for assessment of the role of VDR
in renin regulation without the interference caused by
abnormal calcium and PTH levels; on the other hand, Tg-
KO mice developed hypocalcemia and secondary hyperpar-
athyroidism as seen in VDRKO mice, and these mice allowed
for assessment of VDR’s role in renin regulation in the same
pathophysiological environment as in VDRKO mice. Our
data showed that hVDR overexpression suppressed renin
expression under normal calcium and PTH conditions in Tg
mice, and reconstitution of the JG cells with the hVDR
transgene mostly normalized renin expression in Tg-KO
mice. These data provide compelling evidence that VDR-
mediated regulation of renin by 1,25(OH)2D3 is independent
of calcium and PTH, and PTH plays a very minor role, if any,
in the upregulation of renin in VDRKO mice. It is of note
that, despite the reduction in renin production by the hVDR
transgene, the blood pressure of Tg mice was not changed.
This is not surprising because alteration of renin, in this case
30% reduction in PRA, usually does not lead to alteration in
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Figure 3 | Effect of the hVDR transgene on calcium and PTH
status and renin expression in the VDRKO background. (a)
Serum-ionized calcium levels; and (b) intact PTH levels in Wt,
VDRKO, and Tg-KO mice. **Po0.001 vs Wt (n¼ 4–6). (c) Total RNAs
were isolated from kidneys of Wt, Tg, Tg-KO, and VDRKO mice and
renin mRNA expression was determined by northern blotting. (d)
Quantitative data of renin mRNA based on the northern blot
analyses. *Po0.05 vs Wt; #Po0.05 vs VDRKO (n¼ 4–5).
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blood pressure under normal physiological conditions. For
example, in normotensive healthy human subjects receiving
renin inhibitor aliskiren treatment, blood pressure was
unchanged even plasma Ang II levels was reduced by
75–89%.22
In sum, the main purpose of this Tg study was to address
the relationship among calcium, PTH and 1,25(OH)2D3 in
renin regulation, and together the data unequivocally
confirm that 1,25(OH)2D3 negatively regulates renin gene
expression in vivo through a VDR-dependent, and calcium-
and PTH-independent mechanism.
METHODS
Generation of hVDR transgenic mice
The schematic map of the DNA construct (R1C4.1-hVDR) used to
generate Tg mice is illustrated in Figure 1a. This construct was
generated as follows: the 4.1 kb (from 4100 to þ 6) mouse Ren-1C
gene promoter was released from pR1C-4.1CAT15 by XbaI digestion,
purified and cloned into the XbaI site 50 upstream to the hVDR
coding sequence in pcDNA-hVDR. Then the 130 bp SV40
polyadenylation signal flanked by 50 HindIII and 30 KpnI sites was
cloned into the unique HindIII and KpnI sites 30 downstream to the
hVDR coding sequence. The 6.3 kb R1C4.1-hVDR-PolyA fragment
was cleaved by PmeI, purified and microinjected into the nuclei of
single-cell-stage embryos of C57BL6 according to standard proce-
dures23 by the Transgenic Mouse Facility at the University of
Chicago. Founders carrying the hVDR transgene were identified by
PCR analysis of tail genomic DNA, using hVDR-specific primers
50CGTGTGAATGATGGTGGAGGGAGCC30 (forward), and 50GTCT
TGGTTGCCACAGGTCCAGGAC30 (reverse). Integration of the
transgene into the mouse genome was verified by Southern blot
using 32P-labeled hVDR cDNA as the probe. The animal protocol
was approved by the Institutional Animal Care and Use Committee
at the University of Chicago.
Generation of transgenic VDR-null (Tg-KO) mice
VDRKO mice carrying the hVDR transgene were generated by a
two-step breeding strategy. First step was Tg(þ /)VDR(þ /)
breeding to generate Tg(þ /)VDR(þ /) mice; second step was
Tg(þ /)VDR(þ /)Tg(þ /)VDR(þ /) breeding to obtain
Tg(þ /)VDR(/) and Tg(þ /þ )VDR(/) mice. These mice
were referred as Tg-KO mice.
Northern blot
Northern blot analysis was performed as described previously.24
Briefly, total RNAs were extracted from the kidney using the TriZol
reagent (Invitrogen, Carlsbad, CA, USA). Total RNAs were separated
on an 1% agarose gel containing 0.6 M formaldehyde, transferred
onto a Nylon membrane (MSI, Westborough, MA, USA) and
crosslinked in an UV crosslinker (Bio-Rad, Hercules, CA, USA). The
membranes were hybridized with 32P-labeled cDNA probes accord-
ing to the method of Church and Gilbert.25 Variations in RNA
loading were normalized with 36B4 probe.
Western blot
Kidney samples were placed in the Laemmli sample buffer,26 boiled
for 5 min, and dispersed by sonication. Protein concentrations were
determined as described.24 Western blots were carried out as
described previously.24 Briefly, the kidney lysates were separated by
SDS–polyacrylamide gel electrophoresis, and then transferred onto
Immobolin-P membranes. The membranes were incubated sequen-
tially with primary antibody and peroxidase-conjugated second
antibody, and the antigen was visualized using an enhanced
chemiluminescent kit (Amersham, Piscataway, NJ, USA).
Plasma renin activity
PRA was determined using a commercial kit from DiaSorin
(Stillwater, MN, USA). Briefly, first the renin activity was
determined by measuring the conversion of angiotensinogen to
Ang I, using plasma from bilaterally nephrectomized rats as the
source for angiotensinogen substrate as described previously.27 The
nephrectomized rat plasma provides an excess of renin substrate
(angiotensinogen) for the assay. The amount of Ang I generated was
determined by radioimmunoassays. PRA is expressed as ng(AngI)/
ml(mouse plasma)/h.
Immunohistochemical staining
Kidneys were fixed in 4% formalin made in phosphate-buffered
saline (pH 7.2) overnight, processed, embedded in paraffin, and cut
to 5 mm sections with a microtome. The paraffin sections were
boiled in 10 mM Na citrate solution for 10 min to retrieve the
antigens, and incubated with an anti-VDR antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) at room temperature for 3 h.
After being stained with horseradish peroxidase-conjugated second
antibody the antigen was visualized with a peroxidase substrate
diaminobenzidine kit (Vector Laboratories, Burlingame, CA, USA)
as described previously.28
Measurement of blood pressure
Mouse blood pressure was determined using an invasive left carotid
artery cannulation method described previously.5
Serum-ionized calcium and intact PTH
Serum-ionized calcium levels were determined using a 634 Caþ þ /
pH analyzer. Serum iPTH levels were determined using a
commercial enzyme-linked immunosorbent assay kit as described
previously.5
Statistical analysis
Data were presented as mean±s.e.m. Statistical comparisons were
made using Student’s t-test, with Po0.05 being considered
significant.
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